3 news items
Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
CKPT
DERM
FBIO
15 May 24
issues to address in a resubmission. The CRL did not state any concerns about the clinical data package, safety or labeling for the approvability
Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates
CKPT
FBIO
10 May 24
-party CMO as approvability issues to address in a BLA resubmission. The CRL did not state any concerns about the clinical data package, safety
Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
CKPT
FBIO
22 Mar 24
and safety package in support of cosibelimab. We look forward to providing additional updates in the second quarter
- Prev
- 1
- Next